INCR - InterCure reports record preliminary Q3 revenue of of C$39M
- InterCure ( NASDAQ: INCR ) said Friday it expects to report record Q3 revenue of C$39M, up 63% Y/Y, driven by strong demand for its branded products.
- The company said its annualized run rate was over C$155M, with revenue growth expected to continue in Q4.
- As of Q3-end, InterCure ( INCR ) expanded its medical cannabis pharmacy chain to 25 locations.
- The firm will file its Q3 results on Nov. 15.
For further details see:
InterCure reports record preliminary Q3 revenue of of C$39M